303 related articles for article (PubMed ID: 32169738)
1. NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF.
Jia Y; Ma L; Wang Y; Wang W; Shen C; Wang X; Xu H; Zhao C
Mol Immunol; 2020 Apr; 120():179-186. PubMed ID: 32169738
[TBL] [Abstract][Full Text] [Related]
2. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of NLRC4, NLRP1, and NLRP3, as Components of Inflammasomes, in Chronic Hepatitis B Virus-Infected Patients.
Askari A; Nosratabadi R; Khaleghinia M; Zainodini N; Kennedy D; Shabani Z; Kazemi Arababadi M
Viral Immunol; 2016 Nov; 29(9):496-501. PubMed ID: 27750030
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
[TBL] [Abstract][Full Text] [Related]
5. Differential Activation of NLRP3, AIM2, and IFI16 Inflammasomes in Humans with Acute and Chronic Hepatitis B.
Chen H; He G; Chen Y; Zhang X; Wu S
Viral Immunol; 2018 Nov; 31(9):639-645. PubMed ID: 30222506
[TBL] [Abstract][Full Text] [Related]
6. The NLRP3 inflammasome mediates liver failure by activating procaspase-1 and pro-IL-1 β and regulating downstream CD40-CD40L signaling.
Li Z; Jiang J
J Int Med Res; 2021 Sep; 49(9):3000605211036845. PubMed ID: 34551597
[TBL] [Abstract][Full Text] [Related]
7. The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation.
Molyvdas A; Georgopoulou U; Lazaridis N; Hytiroglou P; Dimitriadis A; Foka P; Vassiliadis T; Loli G; Phillipidis A; Zebekakis P; Germenis AE; Speletas M; Germanidis G
Cytokine; 2018 Oct; 110():389-396. PubMed ID: 29803661
[TBL] [Abstract][Full Text] [Related]
8. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-124a contributes to glucocorticoid resistance in acute-on-chronic liver failure by negatively regulating glucocorticoid receptor alpha.
Wang X; Xu H; Wang Y; Shen C; Ma L; Zhao C
Ann Hepatol; 2020; 19(2):214-221. PubMed ID: 31628069
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis.
Kim SK; Cho YJ; Choe JY
Clin Chim Acta; 2018 Nov; 486():269-274. PubMed ID: 30138619
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage.
Bao S; Zheng J; Li N; Huang C; Chen M; Cheng Q; Li Q; Lu Q; Zhu M; Ling Q; Yu K; Chen S; Shi G
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):147-155. PubMed ID: 28041935
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure.
Zhao Q; Wu CS; Fang Y; Qian Y; Wang H; Fan YC; Wang K
Int J Med Sci; 2019; 16(3):461-469. PubMed ID: 30911280
[TBL] [Abstract][Full Text] [Related]
13. Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation.
Awad F; Assrawi E; Jumeau C; Georgin-Lavialle S; Cobret L; Duquesnoy P; Piterboth W; Thomas L; Stankovic-Stojanovic K; Louvrier C; Giurgea I; Grateau G; Amselem S; Karabina SA
PLoS One; 2017; 12(4):e0175336. PubMed ID: 28403163
[TBL] [Abstract][Full Text] [Related]
14. IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation.
Pang X; Li X; Mo Z; Huang J; Deng H; Lei Z; Zheng X; Feng Z; Xie D; Gao Z
BMC Gastroenterol; 2018 May; 18(1):61. PubMed ID: 29743020
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of peripheral blood mononuclear cell microRNA in hepatitis B-related acute-on-chronic liver failure.
Ding W; Xin J; Jiang L; Zhou Q; Wu T; Shi D; Lin B; Li L; Li J
Sci Rep; 2015 Aug; 5():13098. PubMed ID: 26267843
[TBL] [Abstract][Full Text] [Related]
16. N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus.
Xiong L; Du Y; Zhou T; Du B; Visalath P; Lin L; Bao S; Cai W
J Gastroenterol Hepatol; 2019 Oct; 34(10):1800-1808. PubMed ID: 30771232
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome.
Hou L; Yang L; Chang N; Zhao X; Zhou X; Dong C; Liu F; Yang L; Li L
Front Immunol; 2020; 11():1149. PubMed ID: 32695095
[TBL] [Abstract][Full Text] [Related]
18. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
[TBL] [Abstract][Full Text] [Related]
19. DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure.
Du XX; Shi Y; Yang Y; Yu Y; Lou HG; Lv FF; Chen Z; Yang Q
Liver Int; 2018 Feb; 38(2):229-238. PubMed ID: 28640516
[TBL] [Abstract][Full Text] [Related]
20. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.
Bernsmeier C; Pop OT; Singanayagam A; Triantafyllou E; Patel VC; Weston CJ; Curbishley S; Sadiq F; Vergis N; Khamri W; Bernal W; Auzinger G; Heneghan M; Ma Y; Jassem W; Heaton ND; Adams DH; Quaglia A; Thursz MR; Wendon J; Antoniades CG
Gastroenterology; 2015 Mar; 148(3):603-615.e14. PubMed ID: 25479139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
